Lindbrook Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-378
| Closed | -$1.41K | – | 2694 |
|
2023
Q2 | $1.41K | Buy |
378
+67
| +22% | +$251 | ﹤0.01% | 2286 |
|
2023
Q1 | $1.04K | Buy |
311
+4
| +1% | +$13 | ﹤0.01% | 2444 |
|
2022
Q4 | $1.48K | Buy |
307
+18
| +6% | +$87 | ﹤0.01% | 2362 |
|
2022
Q3 | $2K | Sell |
289
-24
| -8% | -$166 | ﹤0.01% | 1987 |
|
2022
Q2 | $2K | Buy |
+313
| New | +$2K | ﹤0.01% | 1905 |
|
2022
Q1 | – | Sell |
-50
| Closed | – | – | 2469 |
|
2021
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 2070 |
|